148 related articles for article (PubMed ID: 9891461)
1. Expression of lung-resistance protein gene is not associated with platinum drug exposure in lung cancer.
Oguri T; Fujiwara Y; Ochiai M; Fujitaka K; Miyazaki M; Takahashi T; Yokozaki M; Isobe T; Ohune T; Tsuya T; Katoh O; Yamakido M
Anticancer Res; 1998; 18(6A):4159-62. PubMed ID: 9891461
[TBL] [Abstract][Full Text] [Related]
2. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
3. Expression of lung resistance-related protein in transitional cell carcinoma of bladder.
Zhu Y; Kong C; Zeng Y; Sun Z; Gao H
Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883
[TBL] [Abstract][Full Text] [Related]
4. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T
Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576
[TBL] [Abstract][Full Text] [Related]
5. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
6. Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cells.
Ikeda K; Oka M; Narasaki F; Fukuda M; Nakamura T; Nagashima S; Terashi K; Sato S; Kawabata S; Mizuta Y; Soda H; Kohno S
Anticancer Res; 1998; 18(4C):3077-80. PubMed ID: 9713513
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the MRP5 gene is associated with exposure to platinum drugs in lung cancer.
Oguri T; Isobe T; Suzuki T; Nishio K; Fujiwara Y; Katoh O; Yamakido M
Int J Cancer; 2000 Apr; 86(1):95-100. PubMed ID: 10728601
[TBL] [Abstract][Full Text] [Related]
8. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
[TBL] [Abstract][Full Text] [Related]
9. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
10. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
[TBL] [Abstract][Full Text] [Related]
12. Effect of curcumin on lung resistance-related protein (LRP) in retinoblastoma cells.
Thiyagarajan S; Thirumalai K; Nirmala S; Biswas J; Krishnakumar S
Curr Eye Res; 2009 Oct; 34(10):845-51. PubMed ID: 19895312
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
14. Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo.
Koshikawa K; Osada H; Kozaki K; Konishi H; Masuda A; Tatematsu Y; Mitsudomi T; Nakao A; Takahashi T
Oncogene; 2002 Apr; 21(18):2822-8. PubMed ID: 11973641
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
16. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter.
Lange C; Walther W; Schwabe H; Stein U
Biochem Biophys Res Commun; 2000 Nov; 278(1):125-33. PubMed ID: 11071864
[TBL] [Abstract][Full Text] [Related]
17. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
[TBL] [Abstract][Full Text] [Related]
18. [Lung resistance protein analysis in testicular cancer].
Mándoky L; Géczi L; Doleschall Z; Csuka O; Bodrogi I; Bak M
Magy Onkol; 2002; 46(4):339-45. PubMed ID: 12563357
[TBL] [Abstract][Full Text] [Related]
19. Expression of multidrug resistance-related markers in gastric cancer.
Fan K; Fan D; Cheng LF; Li C
Anticancer Res; 2000; 20(6C):4809-14. PubMed ID: 11205224
[TBL] [Abstract][Full Text] [Related]
20. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
Yu SP; Xiong YY; Tian SF
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
